Skip to main content
. 2010 Dec 10;26(7):2281–2289. doi: 10.1093/ndt/gfq709

Table 5.

Middle molecular weight solute removal

Dialyser
Xevonta Hi 23 FX 100 Xenium 210
Amembris® Helixone® Purema®
β2m
 Blood before (mg/L) 18.4 ± 0.4 19.3 ± 0.4 18.6 ± 0.4
 Corrected blood after (mg/L) 6.6 ± 0.3 8.0 ± 0.3 7.5 ± 0.3a,b
 Blood RR (%) 64.3 ± 0.9 58.9 ± 1.0 59.9 ± 1.1a,b
 Dialysate concentration (mg/L) 1.29 ± 0.05 1.14 ± 0.07 0.99 ± 0.05b
 Total dialysate mass (mg) 146 ± 6 130 ± 8 110 ± 7b,c
K (mL/min) 51 ± 3 54 ± 3 30 ± 2b,c
Leptin
 Blood before (μg/L) 34.7 ± 12.3 43.0 ± 17.5 26.0 ± 6.5
 Corrected blood after (mg/L) 15.4 ± 5.1 18.2 ± 7.0 13.4 ± 2.9
 Blood RR (%) 31.8 ± 4.7 27.7 ± 5.2 28.7 ± 4.4
RBP
 Blood before (mg/L) 195.5 ± 26.6 160.4 ± 15.0 206.9 ± 20.5
 Corrected blood after (mg/L) 142.2 ± 18.2 126.0 ± 13.6 163.9 ± 14.7
 Blood RR (%) 22.4 ± 4.0 20.6 ± 4.1 18.2 ± 2.5
 Dialysate concentration (mg/L) 1.58 ± 0.20 1.19 ± 0.14 0.90 ± 0.07b
 Total dialysate mass (mg) 179.4 ± 23.4 136.5 ± 16.3 104.4 ± 8.7b
K (mL/min) 7.0 ± 1.2 4.8 ± 0.6 3.2 ± 0.4b
α1-Antitrypsin
 Blood before (g/L) 1.53 ± 0.05 1.50 ± 0.05 1.42 ± 0.04
 Corrected blood after (mg/L) 1.38 ± 0.04 1.36 ± 0.04 1.29 ± 0.04
 Blood RR (%) 9.4 ± 0.9 8.9 ± 1.0 8.7 ± 0.9
Albumin
 Blood before (g/L) 36.9 ± 0.5 36.5 ± 0.5 36.7 ± 0.4
 Corrected blood after (g/L) 33.6 ± 0.6 33.0 ± 0.5 33.5 ± 0.5
 Blood RR (%) 9.0 ± 0.9 9.2 ± 0.9 8.7 ± 0.8
 Dialysate concentration (mg/L) 1.19 ± 0.14 0.80 ± 0.09 0.66 ± 0.04a,b
 Total dialysate mass (mg) 133.1 ± 15.7 89.4 ± 9.3 71.4 ± 5.4a,b
K (mL/min) 0.017 ± 0.003 0.017 ± 0.003 0.008 ± 0.001b,c
Total proteins
 Blood before (g/L) 64.6 ± 0.8 61.4 ± 0.8 64.1 ± 0.7a,c
 Corrected blood after (g/L) 58.7 ± 0.9 55.8 ± 0.7 58.5 ± 0.7a,c
 Blood RR (%) 9.0 ± 0.8 8.8 ± 1.0 8.6 ± 0.9
 Dialysate concentration (mg/L) 10.7 ± 0.7 7.1 ± 0.5 7.6 ± 0.4a,b
 Total dialysate mass (mg) 1209 ± 74 810 ± 55 809 ± 52a,b
K (mL/min) 0.09 ± 0.01 0.08 ± 0.01 0.05 ± 0.01b,c
a

P < 0.05 Xevonta vs FX.

b

P < 0.05 Xevonta vs Xenium.

c

P < 0.05 FX vs Xenium.